NFE2L2 and cancer: Moreover, mutant KRAS transcriptionally promotes metabolic reprogramming and upregulates Nrf2/NFE2L2, and it plays a critical role in anabolic cancer metabolism by altering glucose and glutamine metabolism KRAS enhances chemoresistance by upregulating Nrf2 signaling, critical for tumor progression.